{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T10:29:17Z","timestamp":1780655357927,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,9,27]],"date-time":"2011-09-27T00:00:00Z","timestamp":1317081600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1756-8722-4-39","type":"journal-article","created":{"date-parts":[[2011,9,28]],"date-time":"2011-09-28T02:57:23Z","timestamp":1317178643000},"source":"Crossref","is-referenced-by-count":16,"title":["Acute myeloid leukemia of donor origin after allogeneic stem cell transplantation from a sibling who harbors germline XPD and XRCC3 homozygous polymorphisms"],"prefix":"10.1186","volume":"4","author":[{"given":"Hilda Rachel","family":"Diamond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Helena","family":"Ornellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Orfao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadete E","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9rcia M","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa S","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto I","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilda","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Lage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayse A","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Moellmann-Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geydson S","family":"da Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Fernando","family":"Bouzas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Abdelhay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,27]]},"reference":[{"key":"173_CR1","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1200\/JCO.2006.05.9048","volume":"25","author":"MC Le Deley","year":"2007","unstructured":"Le Deley MC, Suzan F, Cutuli B, Delaloge S, Shamsaldin A, Linassier C, Clisant S, de Vathaire F, Fenaux P, Hill C: Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer. J Clin Oncol. 2007, 25: 292-300. 10.1200\/JCO.2006.05.9048.","journal-title":"J Clin Oncol"},{"key":"173_CR2","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/jnci\/90.16.1205","volume":"90","author":"DR Budman","year":"1998","unstructured":"Budman DR, Berry DA, Cirrincione CT, Henderson IC, Wood WC, Weiss RB, Ferree CR, Muss HB, Green MR, Norton L, Frei E: Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B. J Natl Cancer Inst. 1998, 90: 1205-1211. 10.1093\/jnci\/90.16.1205.","journal-title":"J Natl Cancer Inst"},{"key":"173_CR3","doi-asserted-by":"crossref","unstructured":"Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet. 1998, 352: 930-942.","DOI":"10.1016\/S0140-6736(98)03301-7"},{"key":"173_CR4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4103\/0019-509X.13774","volume":"41","author":"A Srivastava","year":"2004","unstructured":"Srivastava A, Murari M, Datta NR: Early occurrence of acute myeloid leukemia following adjuvant radiotherapy and higher cumulative dose of cyclophosphamide in carcinoma breast. Indian J Cancer. 2004, 41: 178-180.","journal-title":"Indian J Cancer"},{"key":"173_CR5","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1200\/JCO.2005.05.029","volume":"23","author":"C Praga","year":"2005","unstructured":"Praga C, Bergh J, Bliss J, Bonneterre J, Cesana B, Coombes RC, Fargeot P, Folin A, Fumoleau P, Giuliani R, Kerbrat P, Hery M, Nilsson J, Onida F, Piccart M, Shepherd L, Therasse P, Wils J, Rogers D: Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide. J Clin Oncol. 2005, 23: 4179-4191. 10.1200\/JCO.2005.05.029.","journal-title":"J Clin Oncol"},{"key":"173_CR6","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/sj.leu.2402247","volume":"15","author":"MA Lichtman","year":"2001","unstructured":"Lichtman MA: The stem cell in the pathogenesis and treatment of myelogenous leukemia: a perspective. Leukemia. 2001, 15: 1489-1494. 10.1038\/sj.leu.2402247.","journal-title":"Leukemia"},{"key":"173_CR7","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1200\/JCO.1992.10.7.1103","volume":"10","author":"WR Vogler","year":"1992","unstructured":"Vogler WR, Velez-Garcia E, Weiner RS, Flaum MA, Bartolucci AA, Omura GA, Gerber MC, Banks PL: A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study. J Clin Oncol. 1992, 10: 1103-1111.","journal-title":"J Clin Oncol"},{"key":"173_CR8","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1056\/NEJM199812033392301","volume":"339","author":"PA Cassileth","year":"1998","unstructured":"Cassileth PA, Harrington DP, Appelbaum FR, Lazarus HM, Rowe JM, Paietta E, Willman C, Hurd DD, Bennett JM, Blume KG, Head DR, Wiernik PH: Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. N Engl J Med. 1998, 339: 1649-1656. 10.1056\/NEJM199812033392301.","journal-title":"N Engl J Med"},{"key":"173_CR9","doi-asserted-by":"crossref","unstructured":"INCA\/MS CONDUTAS DO INCA\/MS. Leucemia Miel\u00f3ide Aguda em Adultos. Rev Bras Cancerol. 2002, 48: 313-315.","DOI":"10.32635\/2176-9745.RBC.2002v48n3.2209"},{"key":"173_CR10","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1073\/pnas.051624098","volume":"98","author":"E Levy-Lahad","year":"2001","unstructured":"Levy-Lahad E, Lahad A, Eisenberg S, Dagan E, Paperna T, Kasinetz L, Catane R, Kaufman B, Beller U, Renbaum P, Gershoni-Baruch R: A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers. Proc Natl Acad Sci USA. 2001, 98: 3232-3236. 10.1073\/pnas.051624098.","journal-title":"Proc Natl Acad Sci USA"},{"key":"173_CR11","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/carcin\/24.3.505","volume":"24","author":"X Wu","year":"2003","unstructured":"Wu X, Zhao H, Wei Q, Amos CI, Zhang K, Guo Z, Qiao Y, Hong WK, Spitz MR: XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis. 2003, 24: 505-509. 10.1093\/carcin\/24.3.505.","journal-title":"Carcinogenesis"},{"key":"173_CR12","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.1182\/blood-2004-06-2161","volume":"104","author":"JM Allan","year":"2004","unstructured":"Allan JM, Smith AG, Wheatley K, Hills RK, Travis LB, Hill DA, Swirsky DM, Morgan GJ, Wild CP: Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy. Blood. 2004, 104: 3872-3877. 10.1182\/blood-2004-06-2161.","journal-title":"Blood"},{"key":"173_CR13","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1158\/1078-0432.CCR-03-0372","volume":"10","author":"C Seedhouse","year":"2004","unstructured":"Seedhouse C, Faulkner R, Ashraf N, Das-Gupta E, Russell N: Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia. Clin Cancer Res. 2004, 10: 2675-2680. 10.1158\/1078-0432.CCR-03-0372.","journal-title":"Clin Cancer Res"},{"key":"173_CR14","first-page":"771","volume":"4","author":"RM Dufloth","year":"2005","unstructured":"Dufloth RM, Costa S, Schmitt F, Zeferino LC: DNA repair gene polymorphisms and susceptibility to familial breast cancer in a group of patients from Campinas, Brazil. Genet Mol Res. 2005, 4: 771-782.","journal-title":"Genet Mol Res"},{"key":"173_CR15","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1007\/s00018-009-8737-y","volume":"66","author":"T Nouspikel","year":"2009","unstructured":"Nouspikel T: DNA repair in mammalian cells: Nucleotide excision repair: variations on versatility. Cell Mol Life Sci. 2009, 66: 994-1009. 10.1007\/s00018-009-8737-y.","journal-title":"Cell Mol Life Sci"},{"key":"173_CR16","doi-asserted-by":"publisher","first-page":"(10):1389","DOI":"10.3324\/haematol.11034","volume":"92","author":"G Leone","year":"2007","unstructured":"Leone G, Pagano L, Ben-Yehuda D, Voso MT: Therapy-related leukemia and myelodysplasia: susceptibility and incidence. Haematologica. 2007, 92: (10):1389-1398.","journal-title":"Haematologica"},{"key":"173_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/jnci\/djk028","volume":"99","author":"D Hershman","year":"2007","unstructured":"Hershman D, Neugut AI, Jacobson JS, Wang J, Tsai WY, McBride R, Bennett CL, Grann VR: Acute Myeloid Leukemia or Myelodysplastic Syndrome Following Use of Granulocyte Colony-Stimulating Factors During Breast Cancer Adjuvant Chemotherapy. J Natl Cancer Inst. 2007, 99: 196-205. 10.1093\/jnci\/djk028.","journal-title":"J Natl Cancer Inst"},{"key":"173_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0165-4608(91)90246-Q","volume":"55","author":"J Pedersen-Bjergaard","year":"1991","unstructured":"Pedersen-Bjergaard J, Philip P: Two different classes of therapy-related and de-novo acute myeloid leukemia?. Cancer Genet Cytogenet. 1991, 55: 119-124. 10.1016\/0165-4608(91)90246-Q.","journal-title":"Cancer Genet Cytogenet"},{"key":"173_CR19","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1080\/10428190500125705","volume":"46","author":"MJ Park","year":"2005","unstructured":"Park MJ, Park YH, Ahn HJ, Choi W, Paik KH, Kim JM, Chang YH, Ryoo BY, Yang SH: Secondary hematological malignancies after breast cancer chemotherapy. Leuk Lymphoma. 2005, 46: 1183-1188. 10.1080\/10428190500125705.","journal-title":"Leuk Lymphoma"},{"key":"173_CR20","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1200\/JCO.2003.03.114","volume":"21","author":"RE Smith","year":"2003","unstructured":"Smith RE, Bryant J, DeCillis A, Anderson S: Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin- cyclophosphamide adjuvant therapy for operable breast cancer: The national surgical adjuvant breast and bowel project experience. J Clin Oncol. 2003, 21: 1195-1204. 10.1200\/JCO.2003.03.114.","journal-title":"J Clin Oncol"},{"key":"173_CR21","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1200\/JCO.2003.08.137","volume":"21","author":"M Crump","year":"2003","unstructured":"Crump M, Tu D, Shepherd L, Levine M, Bramwell V, Pritchard K: Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. 2003, 21: 3066-3071. 10.1200\/JCO.2003.08.137.","journal-title":"J Clin Oncol"},{"key":"173_CR22","first-page":"453","volume-title":"Hematology Am Soc Hematol Educ Program","author":"RA Larson","year":"2007","unstructured":"Larson RA: Etiology and management of therapy-related myeloid leukemia. Hematology Am Soc Hematol Educ Program. 2007, 453-459."},{"key":"173_CR23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/gcc.10040","volume":"33","author":"JD Rowley","year":"2002","unstructured":"Rowley JD, Olney HJ: International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy-related myelodysplastic syndromes and acute leukemia: overview report. Genes Chromosomes Cancer. 2002, 33: 331-345. 10.1002\/gcc.10040.","journal-title":"Genes Chromosomes Cancer"},{"key":"173_CR24","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1182\/blood.V94.2.803","volume":"94","author":"RA Larson","year":"1999","unstructured":"Larson RA, Wang Y, Banerjee M, Wiemels J, Hartford C, Le Beau MM, Smith MT: Prevalence of the inactivating 609C-[T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood. 1999, 94: 803-807.","journal-title":"Blood"},{"key":"173_CR25","doi-asserted-by":"publisher","first-page":"11592","DOI":"10.1073\/pnas.191211198","volume":"98","author":"JM Allan","year":"2001","unstructured":"Allan JM, Wild CP, Rollinson S, Willett EV, Moorman AV, Dovey GJ, Roddam PL, Roman E, Cartwright RA, Morgan GJ: Polymorphisms in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. Proc Natl Acad Sci USA. 2001, 98: 11592-11597. 10.1073\/pnas.191211198.","journal-title":"Proc Natl Acad Sci USA"},{"key":"173_CR26","first-page":"4091","volume":"6","author":"T Naoe","year":"2000","unstructured":"Naoe T, Takeyama K, Yokozawa T, Kiyoi H, Seto M, Uike N, Ino T, Utsunomiya A, Maruta A, Jin-nai I, Kamada N, Kubota Y, Nakamura H, Shimazaki C, Horiike S, Kodera Y, Saito H, Ueda R, Wiemels J, Ohno R: Analysis of genetic polymorphism in NQ01, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia\/myelodysplastic syndrome and de novo acute myeloid leukemia. Clin Cancer Res. 2000, 6: 4091-4095.","journal-title":"Clin Cancer Res"},{"key":"173_CR27","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.1182\/blood-2002-04-1152","volume":"100","author":"C Seedhouse","year":"2002","unstructured":"Seedhouse C, Bainton R, Lewis M, Harding A, Russell N, Das-Gupta E: The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia. Blood. 2002, 100: 3761-3766. 10.1182\/blood-2002-04-1152.","journal-title":"Blood"},{"key":"173_CR28","first-page":"1513","volume":"11","author":"EL Goode","year":"2002","unstructured":"Goode EL, Ulrich CM, Potter JD: Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev. 2002, 11: 1513-1530. Erratum in: Cancer Epidemiol. Biomarkers Prev 2003; 12(10):1119","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"173_CR29","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1182\/blood-2006-05-022111","volume":"109","author":"N Kuptsova","year":"2007","unstructured":"Kuptsova N, Kopecky KJ, Godwin J, Anderson J, Hoque A, Willman CL, Slovak ML, Ambrosone CB: Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWGOG clinical trials. Blood. 2007, 109: 3936-3944. 10.1182\/blood-2006-05-022111.","journal-title":"Blood"},{"key":"173_CR30","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1158\/1078-0432.CCR-04-1101","volume":"11","author":"J Gu","year":"2005","unstructured":"Gu J, Zhao H, Dinney CP, Zhu Y, Leibovici D, Bermejo CE, Grossman HB, Wu X: Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer. Clin Cancer Res. 2005, 11: 1408-1415. 10.1158\/1078-0432.CCR-04-1101.","journal-title":"Clin Cancer Res"},{"key":"173_CR31","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1182\/blood-2006-07-021980","volume":"109","author":"CM Flynn","year":"2007","unstructured":"Flynn CM, Kaufman DS: Donor cell leukemia: insight into cancer stem cells and the stem cell niche. Blood. 2007, 109: 2688-2692.","journal-title":"Blood"},{"key":"173_CR32","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.1182\/blood-2010-12-326322","volume":"117","author":"H Xiao","year":"2011","unstructured":"Xiao H, Shi J, Luo Y, Tan Y, He J, Xie W, Zhang L, Wang Y, Liu L, Wu K, Yu X, Cai Z, Lin M, Ye X, Huang H: First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation. Blood. 2011, 117: 5257-5260. 10.1182\/blood-2010-12-326322.","journal-title":"Blood"},{"key":"173_CR33","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1097\/00000478-199809000-00013","volume":"22","author":"HP Horny","year":"1998","unstructured":"Horny HP, Sillaber C, Menke D, Kaiserling E, Wehrmann M, Stehberger B, Chott A, Lechner K, Lennert K, Valent P: Diagnostic value of immunostaining for tryptase in patients with mastocytosis. Am J Surg Pathol. 1998, 22: 1132-1140. 10.1097\/00000478-199809000-00013.","journal-title":"Am J Surg Pathol"},{"key":"173_CR34","first-page":"72","volume":"28","author":"N Quattrin","year":"1978","unstructured":"Quattrin N: Follow up of sixty-two cases of acute basophilic leukemia. Biomedicine. 1978, 28: 72-79.","journal-title":"Biomedicine"},{"key":"173_CR35","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ajcp\/96.2.160","volume":"96","author":"LC Peterson","year":"1991","unstructured":"Peterson LC, Parkin JL, Arthur DC, Brunning RD: Acute basophilic leukemia: a clinical, morphologic and cytogenetic study of eight cases. Am J Clin Pathol. 1991, 96: 160-170.","journal-title":"Am J Clin Pathol"},{"key":"173_CR36","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1080\/10428190310001598053","volume":"45","author":"T Seth","year":"2004","unstructured":"Seth T, Vora A, Bhutani M, Ganessan K, Jain P, Kochupillai V: Acute basophilic leukemia with t(8;21). Leuk Lymphoma. 2004, 45: 605-608. 10.1080\/10428190310001598053. Erratum in: Leuk Lymphoma 2004; 45(6):1311","journal-title":"Leuk Lymphoma"}],"container-title":["Journal of Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-8722-4-39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1756-8722-4-39\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-8722-4-39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T03:08:38Z","timestamp":1686366518000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/1756-8722-4-39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,27]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["173"],"URL":"https:\/\/doi.org\/10.1186\/1756-8722-4-39","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,27]]},"article-number":"39"}}